Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell BP (BP.) by Alan Oscroft in The Motley Fool
- Buy Persimmon (PSN) by James Beard in The Motley Fool
- Add Pershing Square Holdings Ltd NPV (PSH) by Ben McPoland in The Motley Fool
- Neutral Diploma (DPLM) by JP Morgan
- Buy Breedon Group (BREE) by Deutsche Bank
- Sell JD Sports Fashion (JD.) by Deutsche Bank
- Buy Grainger (GRI) by Deutsche Bank
- Buy Close Brothers Group (CBG) by Deutsche Bank
- Buy Spirent Communications (SPT) by Deutsche Bank
- Buy PZ Cussons (PZC) by Deutsche Bank
- Buy Norcros (NXR) by Deutsche Bank
- Avoid Thorpe (F.W.) (TFW) by Steve Moore in ShareProphets
- Strong Buy Eco buildings Group (ECOB) by Hot Stock Rockets in ShareProphets
- Buy Ariana Resources (AAU) by Hot Stock Rockets in ShareProphets
- Watch JD Sports Fashion (JD.) by Steve Moore in ShareProphets
- Avoid Speedy Hire (SDY) by Steve Moore in ShareProphets
- Watch Legal & General Group (LGEN) by James Beard in The Motley Fool
- Sell Sage Group (SGE) by Canaccord Genuity
- Buy Michelmersh Brick Holdings (MBH) by Canaccord Genuity
- Buy B&M European Value Retail S.A. (DI) (BME) by Canaccord Genuity
Verici DX (VRCI) Share Price
Health Care Sector
NOTE: This is based on 10 open tips for Verici DX (VRCI)
| Latest Bid : 3.25p | Latest Ask : 3.50p |
| High Today : 3.48p | Low Today : 3.31p |
| This Years High : 11.75p | This Years Low : 2.88p |
| Volume : 52,926 | MKT Cap : £8.18M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Verici DX (VRCI) Overview
Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.Verici DX (VRCI) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-10-11 14:50:00 11/10/2024 | 32.50% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 16:05:00 14/02/2024 | 60.29% |
| Avoid | Steve Moore | Premium Only | 2023-11-15 14:35:00 15/11/2023 | 62.50% |
| Avoid | Steve Moore | Premium Only | 2023-07-20 16:25:00 20/07/2023 | 70.65% |
| Watch | Steve Moore | Premium Only | 2023-07-03 11:40:00 03/07/2023 | – |
Verici DX (VRCI) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 3.25p | Latest Ask : 3.50p |
| High Today : 3.48p | Low Today : 3.31p |
| This Years High : 11.75p | This Years Low : 2.88p |
| Volume : 52,926 | MKT Cap : £8.18M |
Verici DX Overview
Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Verici DX Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2024-10-11 14:50:00 11/10/2024 | 32.50% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 16:05:00 14/02/2024 | 60.29% |
| Avoid | Steve Moore | Premium Only | 2023-11-15 14:35:00 15/11/2023 | 62.50% |
| Avoid | Steve Moore | Premium Only | 2023-07-20 16:25:00 20/07/2023 | 70.65% |
| Watch | Steve Moore | Premium Only | 2023-07-03 11:40:00 03/07/2023 | – |